Position in LLY
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$2,052,224
+$693,724 QoQ
Shares Held
1,711
+15.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#2,476
of 4,605 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026SUMMITRY LLC holds $46,849,010 across 11 Drug Manufacturers - General names. LLY ranks #3 (4.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AMGN |
Amgen Inc
|
75,057 | $27,179,640 | |
| 2 | JNJ |
Johnson & Johnson
|
51,089 | $12,975,073 | |
| 3 | LLY |
ELI LILLY & Co
This page
|
1,711 | $2,052,224 | |
| 4 | ABBV |
AbbVie Inc.
|
4,563 | $1,148,233 | |
| 5 | BIIB |
Biogen Inc.
|
4,137 | $893,840 | |
| 6 | MRK |
Merck & Co., Inc.
|
6,279 | $806,851 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
8,531 | $491,556 | |
| 8 | NVS |
Novartis AG
|
2,464 | $386,158 |
All Filings in LLY
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,052,224 | 1,711 | Shares | Sole | 2026-07-21 | |
| 2026-03-31 | $1,358,500 | 1,477 | Shares | Sole | 2026-05-22 | |
| 2025-12-31 | $901,656 | 839 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $586,747 | 769 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $343,772 | 441 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $338,623 | 410 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $304,168 | 394 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $483,723 | 546 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $263,465 | 291 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $265,284 | 341 | Shares | Sole | 2024-05-06 | |
| No filing history on record for this holder in this stock. | ||||||